Bottom Line: Although margins are seasonally at their weakest currently, Tesoro Corporation ( TSO ) and Phillips 66 ( PSX ) Analyst Days should reconfirm some key attractions of the US
Roche Holding ( RHHBY ) recently announced survival data from its phase III CLEOPATRA study on Perjeta (pertuzumab). Data from the study showed that Perjeta plus Roche’s existing breast
FXstreet.com (Córdoba) – The yen weakened and gave up most of its earlier gains versus the dollar and the euro amid reports that the Bank of Japan could boost its asset purchases and the